Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

ZEPHYRHILLS — Former Zephyrhills High football coach Tom Fisher, who spent the better part of two decades carving highly ...

"The Miami Project and the University of Miami are renowned for their pioneering research in neural interfaces for the treatment of debilitating neurological conditions," Neuralink co-founder and COO ...

The crowd surged into the freezing Atlantic Ocean in the latest in a series of winter plunges at the Jersey Shore.

Neuralink, the neurotechnology company founded by Elon Musk, has announced an exciting breakthrough in brain-machine ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

For decades, NFL highlight reels have used a magic formula — a rush of swelling music here, some hypnotic slow motion there — ...